`

Targazyme

Biotechnology Research

Specialities :

Stem cells

Immunotherapy

Regenerative medicine

Biotechnology

And drug development

Sign Up to View More

Revenue

1M - 10M

Total Funding

--

Size

11 - 50

About Us

Targazyme Inc. is a San Diego-based, clinical-stage biopharmaceutical company developing novel enzyme-based platform technologies and products to improve clinical efficacy and cost of care outcomes for cell therapy, immunotherapies for autoimmune diseases and cancer, stem cell transplantation, gene therapy and regenerative medicine. The Companys clinical-grade fucosyltransferase enzymes and small molecule products (TZ101 and TZ102) are off-the-shelf biologic products used at the point-of-care to treat therapeutic cells immediately before infusion into the patient using a simple procedure that is easily incorporated into existing medical practice. The Company has received worldwide patents, multiple FDA orphan drug designations, has an open investigational new drug application (IND) with multiple ongoing clinical studies and a Phase 3 Special Protocol Assessment (SPA) with the FDA. Targazymes fucosylation technology has received numerous medical and scientific awards from institu...

Sign Up to View More

Contact Information

Carlsbad , California , United States

emailIcon

info@targazyme.com

Sign Up to View in Detail

Targazyme Org Chart

No data available

Sign Up to View More Org Chart

Employees

Total Employees:
6

Top Contacts:
0

C-Level 0	VP - Level-
Director-	Manager-
Others6

Employees Working At Targazyme

Audrey Lazarus

Senior Vice President Regulatory Affairs and Quality Assurance

Armin Reitmair

Vice President of Translational Research

Gopal Ramakrishnan

Scientist and Project Manager

William Hoo

Senior Director RD CMC

Lynnet Koh

Executive ChairmanFounder

Sign Up to View More Employees of Targazyme

Targazyme Email Formats

No data available

Tech Stack Used By Targazyme

A quick view of products employed by Targazyme

DR

Director

Frequently Asked Questions About Targazyme

What does Targazyme do?+

Targazyme Inc. is a San Diego-based, clinical-stage biopharmaceutical company developing novel enzyme-based platform technologies and products to improve clinical efficacy and cost of care outcomes for cell therapy, immunotherapies for autoimmune diseases and cancer, stem cell transplantation, gene therapy and regenerative medicine. The Companys clinical-grade fucosyltransferase enzymes and small molecule products (TZ101 and TZ102) are off-the-shelf biologic products used at the point-of-care to treat therapeutic cells immediately before infusion into the patient using a simple procedure that is easily incorporated into existing medical practice. The Company has received worldwide patents, multiple FDA orphan drug designations, has an open investigational new...

What are Targazyme's specialties? +

Stem cells,immunotherapy,regenerative medicine,biotechnology,and drug development

What is Targazyme's industry? +

Targazyme operates in the Biotechnology research industry.

What is Targazyme's revenue? +

Targazyme's revenue is 1m - 10m

What is Targazyme's company size? +

Targazyme has 11 - 50 employees.

The Go-to Sales Technology According to G2

G2 Badges Map

Get Started With Clodura

Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Sign Up For Free

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Sign Up For Free

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.

Sign Up For Free